Desoxyn and Neurontin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Desoxyn and Neurontin. Common interactions include drug ineffective among females and loss of consciousness among males.

The phase IV clinical study analyzes what interactions people who take Desoxyn and Neurontin have. It is created by eHealthMe based on reports of 55 people who take Desoxyn and Neurontin from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Aug, 18, 2022

55 people who take Desoxyn and Neurontin together, and have interactions are studied.


What is Desoxyn?

Desoxyn has active ingredients of methamphetamine hydrochloride. It is often used in attention deficit hyperactivity disorder. eHealthMe is studying from 834 Desoxyn users for its effectiveness, alternative drugs and more.

What is Neurontin?

Neurontin has active ingredients of gabapentin. It is often used in neuralgia. eHealthMe is studying from 101,795 Neurontin users for its effectiveness, alternative drugs and more.

Number of Desoxyn and Neurontin reports submitted per year:

Desoxyn and Neurontin drug interactions.

Common Desoxyn and Neurontin drug interactions by gender *:

female:

  1. Drug ineffective
  2. Hypoaesthesia
  3. Blood pressure increased
  4. Burning mouth syndrome
  5. Clumsiness
  6. Craniocerebral injury
  7. Fall
  8. Head injury
  9. Psychotic disorder
  10. Skin injury

male:

  1. Loss of consciousness
  2. Road traffic accident
  3. Hepatic steatosis
  4. Infection
  5. Liver disorder
  6. Pneumonia
  7. Pneumonia bacterial
  8. Post procedural bile leak
  9. Accident
  10. Amnesia

Common Desoxyn and Neurontin drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Completed suicide

20-29:

  1. Hypertension
  2. Laryngitis
  3. Oedema peripheral
  4. Weight increased

30-39:

n/a

40-49:

  1. Gastroenteritis
  2. Gastrooesophageal reflux disease
  3. Hepatic steatosis
  4. Infection
  5. Liver disorder
  6. Pneumonia bacterial
  7. Post procedural bile leak
  8. Hypersensitivity
  9. Brain injury
  10. Burning mouth syndrome

50-59:

  1. Amnesia
  2. Murder
  3. Road traffic accident

60+:

n/a

Common conditions people have *:

  1. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 41 people, 74.55%
  2. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 11 people, 20.00%
  3. Fatigue (feeling of tiredness): 6 people, 10.91%
  4. Burning Mouth Syndrome (pain in the mouth and burning sensation on tongue): 6 people, 10.91%
  5. Ill-Defined Disorder: 5 people, 9.09%
  6. Overdose: 4 people, 7.27%
  7. Migraine (headache): 4 people, 7.27%

* Approximation only. Some reports may have incomplete information.

Do you take Desoxyn and Neurontin?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related publications that referenced our studies

Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Common Desoxyn and Neurontin interactions:

Browse all drug interactions of Desoxyn and Neurontin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Desoxyn interactions:

Browse all interactions between Desoxyn and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Neurontin interactions:

Browse all interactions between Neurontin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on methamphetamine hydrochloride and gabapentin (the active ingredients of Desoxyn and Neurontin, respectively), and Desoxyn and Neurontin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Desoxyn and Neurontin.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: